GlobeNewswire 4/15/2021 22nd Century Stands Fully Prepared to Enable New Zealand Proposal to Advance Nationwide Smoke-Free A...
GlobeNewswire 4/8/2021 22nd Century Group Regulatory Science VP Joins FDLI Tobacco and Nicotine Products Committee
GlobeNewswire 4/1/2021 Multiple Former FDA Commissioners Voice Support for Reduced Nicotine Mandate; Proposed Legislation W...
GlobeNewswire 3/19/2021 Becerra Confirmation Boosts 22nd Century’s Position to Disrupt Tobacco Industry
GlobeNewswire 3/12/2021 22nd Century Group Receives Additional $3.7 Million from Cash Exercise of Outstanding Warrants
GlobeNewswire 3/11/2021 22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full...
GlobeNewswire 3/4/2021 22nd Century Group Receives $8.1 Million from Cash Exercise of Outstanding Warrants
GlobeNewswire 3/3/2021 22nd Century Group Secures Exclusive Agreement with CannaMetrix to Accelerate Commercialization of N...
GlobeNewswire 2/25/2021 22nd Century Group to Host Webcast to Discuss Fourth Quarter and Full-Year 2020 Results
GlobeNewswire 2/24/2021 22nd Century Group Provides Business Update Letter from CEO
GlobeNewswire 2/10/2021 22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Developm...
GlobeNewswire 1/28/2021 22nd Century Group to Relocate Headquarters to Buffalo’s Thriving Larkinville District
GlobeNewswire 1/26/2021 The Buffalo News Op-ed: 22nd Century CEO Urges FDA to Proceed with Plan to Limit Nicotine Levels in ...
GlobeNewswire 1/19/2021 Federal Court Dismisses Securities Class Action Lawsuit Against 22nd Century Group
GlobeNewswire 1/11/2021 22nd Century Group Expands VLN® Tobacco Growing Program to Support Anticipated Demand of the Company...
GlobeNewswire 12/17/2020 22nd Century Group Achieves Breakthrough Hemp/Cannabis GMO Technology; Granted New Patent for Contro...
GlobeNewswire 12/8/2020 22nd Century Receives Order for 3.6 Million New SPECTRUM® Variable Nicotine Cigarettes for U.S. Gove...
GlobeNewswire 12/4/2020 22nd Century Group to Present at 13th Annual LD Micro Main Event Conference
GlobeNewswire 11/24/2020 22nd Century’s Vice President of Regulatory Science Publishes Important Public Policy Article
GlobeNewswire 11/18/2020 22nd Century Group CEO James A. Mish to Speak at Cowen 2020 Boston Cannabis Conference
GlobeNewswire 11/16/2020 22nd Century Group to Present at the Virtual Fall Investor Summit on November 17
GlobeNewswire 11/5/2020 22nd Century Group Reports Financial Results and Business Highlights for the Third Quarter 2020
GlobeNewswire 10/22/2020 22nd Century Group to Host Third Quarter 2020 Webcast and Conduct Quarterly Q&A
GlobeNewswire 10/19/2020 22nd Century Group to Highlight its Reduced Nicotine Technology at The Food and Drug Law Institute’s...
GlobeNewswire 10/14/2020 22nd Century Group Achieves Breakthrough Technology; Granted New Patent for Reducing Nicotine in Tob...